ETENRU

Novo Nordisk Estonia OÜ

Osaühing · 16722379 · Registrisse kantud

Download PDFDownload CSV

Activity

Novo Nordisk Estonia OÜ is a medium enterprise in trade, with declared activity “Ravimite ja muude apteegikaupade hulgimüük” (EMTAK 46461). Annual revenue stands at 28.23 M € with 18 employees, ranks #207 of 27,719 in trade.

Trade

Court decisions

Supreme Court (Riigikohus) decisions naming this company. Source: Riigikohus.

Overview (2024)

Revenue
28.23 M €
▲ 368%YoY
▲ 1000+×above industry median
Profit
1.01 M €
▲ 366%YoY
Profit margin
3.6%
Employees
18
▲ 12.5%YoY
Revenue per employee
1.57 M €
Cost per employee
95.4 k €
Equity
1.43 M €

Growth

Revenue
28.23 M €
▲ 368%
1y
—
3y CAGR
—
5y CAGR
Profit
1.01 M €
▲ 366%
1y
—
3y CAGR
—
5y CAGR
Employees
18
▲ 12.5%
1y
—
3y CAGR
—
5y CAGR

Trends

Revenue trend
28.23 M €
Profit trend
1.01 M €
Headcount trend
18

Revenue to profit

28.2 M €Revenue−1.7 M €Labor cost−25.5 M €Other costs1.0 M €Profit

Capital structure

  • Equity19%
  • Liabilities81%

Financials

YearRevenueGrowthProfitMarginEmployeesRevenue per employeeEquity
2024 ✓28.23 M €▲ 368%1.01 M €4%181.57 M €1.43 M €
2023 ✓6.03 M €—217.4 k €4%16376.7 k €417.4 k €

Similar companies

Same industry, comparable revenue.

Official announcements

Bankruptcy notices, liquidation notices, and other official statements about the company.

View announcements on Ametlikud Teadaanded →

Court rulings

Public court decisions where the company or its registry code is mentioned.

Search court rulings on Riigi Teataja →

General info

Shareholders

Equity holders ranked by ownership percentage.

Beneficial owners

Individuals who ultimately own or control the company.

Board (2)

Data sources

firmaotsing.ee aggregates data from Estonian public registries. Each row links to the original source.